Dennis Gillings will step down as the CEO of Quintiles, the world's largest biopharmaceutical services company. Gillings, who founded the company more than 30 years ago, will remain as chairman and will be replaced by Tom Pike, a long-time executive with Accenture Ltd.
No comments:
Post a Comment